The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival

Musa Yilmaz, Hagop Kantarjian, Xuemei Wang, Joseph D. Khoury, Farhad Ravandi, Jeffrey Jorgensen, Nicholas J. Short, Sanam Loghavi, Jorge Cortes, Guillermo Garcia-Manero, Tapan Kadia, Koji Sasaki, Marina Konopleva, Koichi Takahashi, William Wierda, Nitin Jain, Srdan Verstovsek, Zeev Estrov, Prithviraj Bose, Sherry PierceRebecca Garris, Susan O'Brien, Elias Jabbour

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival'. Together they form a unique fingerprint.

Medicine & Life Sciences